Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

NCT00428922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Bevacizumab
DRUG: Docetaxel

Sponsor

Bhuvaneswari Ramaswamy

Collaborators

[object Object]
[object Object]
[object Object]